Healthy
Conditions
Brief summary
The present study will seek to quantify the muscle protein synthetic response to mycoprotein feeding, comparing it to milk protein as a gold standard and heavily researched positive control
Interventions
Mycoprotein protein beverage
Milk protein beverage
Sponsors
Study design
Eligibility
Inclusion criteria
• BMI between 18 and 30 -
Exclusion criteria
* Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes) * Any diagnosed cardiovascular disease or hypertension. * Elevated blood pressure at the time of screening (e.g. blood pressure of ≥140/90mmHg). * Chronic use of any prescribed or over the counter pharmaceuticals. * A personal or family history of epilepsy, seizures or schizophrenia. * Anyone with previous motor disorders. * An allergy to mycoprotein / Quorn, penicillin, or milk.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle fractional synthetic rate (muscle protein synthesis) | 7.5 hours |
Secondary
| Measure | Time frame |
|---|---|
| Plasma amino acid concentration | 7.5 hours |
| Serum insulin concentration | 7.5 hours |
| Molecular markers of muscle anabolism | 7.5 hours |
Countries
United Kingdom